IPO registrations (S-1, F-1) · Registrants

Liquidia Technologies Inc

SEC CIK
1330436 · filings on EDGAR ↗
Registration
Form S-1, first filed 2018-06-28, last 2019-03-18; 2 initial registrations, 3 amendments
Outcome
Final prospectus filed 2018-07-26; declared effective 2018-07-25
Industry (SIC)
Surgical & Medical Instruments & Apparatus 3841
Incorporated in
DE
Business address
419 DAVIS DRIVE, SUITE 100, Durham, NC 27713
EDGAR entity type
operating
Insiders and CEO pay
Liquidia Technologies Inc on the corporate pages

Offering terms

Final price
$11.00 per share (424B4 filed 2018-07-26, an initial public offering)
Shares sold
4,545,455
Gross proceeds
$50,000,005 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol LQDA
Lead underwriters
Jefferies; Cowen
Syndicate
Needham & Company; Wedbush Securities

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 13

FiledFormWhat it isName as filedEDGAR
2018-06-28S-1S-1 (registration)Liquidia Technologies Inc0001047469-18-004801 ↗
2018-07-13S-1/AS-1/A (amendment)Liquidia Technologies Inc0001047469-18-005019 ↗
2018-07-23S-1/AS-1/A (amendment)Liquidia Technologies Inc0001047469-18-005112 ↗
2018-07-24S-1/AS-1/A (amendment)Liquidia Technologies Inc0001047469-18-005147 ↗
2018-07-25EFFECTEFFECT (declared effective)Liquidia Technologies Inc9999999995-18-001872 ↗
2018-07-26424B4424B4 (final prospectus)Liquidia Technologies Inc0001047469-18-005173 ↗
2019-03-18S-1S-1 (registration)Liquidia Technologies Inc0001047469-19-001375 ↗
2019-03-20EFFECTEFFECT (declared effective)Liquidia Technologies Inc9999999995-19-000480 ↗
2019-03-21424B4424B4 (final prospectus)Liquidia Technologies Inc0001047469-19-001505 ↗
2019-09-10EFFECTEFFECT (declared effective)Liquidia Technologies Inc9999999995-19-002053 ↗
2020-02-13EFFECTEFFECT (declared effective)Liquidia Technologies Inc9999999995-20-000355 ↗
2020-11-20EFFECTEFFECT (declared effective)Liquidia Technologies Inc9999999995-20-003253 ↗
2020-11-20EFFECTEFFECT (declared effective)Liquidia Technologies Inc9999999995-20-003255 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2018-07-24S-1/Aregistration statement$0.01--0primary document; price linedocument ↗
2018-07-26424B4final prospectus$11.004,545,455$50,000,005Nasdaq LQDA4primary document; price sentence, shares headline, proceeds table, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Adair JasonOfficerV.P., Bsnss Dvlpmnt and Strtgy; V.P., Buisness Dev. & Strategy22018–2019
Albury TimothyOfficerSVP, Chief Accounting Officer52018–2019
Alexandria Venture Investments, LLCTenPercentOwner22018
AL WEALTH PARTNERS PTE. LTD.TenPercentOwner22018
ALWP CAPITAL SPC LTDTenPercentOwner22018
Amereus Group PTE LTDTenPercentOwner22018
BARRETT M JAMESTenPercentOwner22018
BARRIS PETER JTenPercentOwner22018
BASKETT FORESTTenPercentOwner22018
Bathurst Enterprises LtdTenPercentOwner42018
Bill & Melinda Gates FoundationTenPercentOwner22018
Bloch Stephen MDirector72018–2020
Canaan Partners VIII LLCTenPercentOwner42018–2020
Canaan VIII LPTenPercentOwner42018–2020
DeSimone JosephTenPercentOwner12018
DeSimone SuzanneTenPercentOwner12018
Eagle Holding Co ITenPercentOwner22018
Eagle Holding Co II, LLCTenPercentOwner22018
Fowler Neal FranklinDirector,OfficerChief Executive Officer52018–2020
Garden East LtdTenPercentOwner22018
GLAXOSMITHKLINE PLCOther; TenPercentOwner22018
Glidden ShawnOfficerSVP, Legal Affairs and Scrtry; VP,Legal Affairs and Secretary22018–2019
GORDON KEVIN KOfficerPresident and CFO52018–2019
Jaguar Holding Co IITenPercentOwner22018
Jaguar Holding Co I, LLCTenPercentOwner22018
KERINS PATRICK JTenPercentOwner22018
Kirsch Arthur SDirector62018–2020
Leerink Revelation Healthcare Fund I GP, L.P.TenPercentOwner22018
LEERINK REVELATION HEALTHCARE FUND I, L.P.TenPercentOwner22018
Lippe Robert AOfficerChief Operations Officer32018–2020
Mario Family Credit LLC Series DTenPercentOwner22018
Mario JeremyTenPercentOwner22018
Mathers Edward TDirector22018
Maynor BenjaminOfficerSVP, Research and Development62018–2020
Medical Mutual Holdings, Inc.TenPercentOwner22018
Melmotte LLCTenPercentOwner22018
Morningside Venture Investments LtdTenPercentOwner22018
NEA 12 GP, LLCTenPercentOwner22018
NEA Partners 12, Limited PartnershipTenPercentOwner22018
New Enterprise Associates 12, Limited PartnershipTenPercentOwner22018
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCTenPercentOwner22018
Roscigno Robert FOfficerSVP, Product Development32018–2020
RUDNICK SETHDirector32018–2020
SANDELL SCOTT DTenPercentOwner22018
SINGH RAMANDirector42018–2020
SNYDERMAN RALPHDirector42018–2020
Sovereign's Capital II, LPTenPercentOwner22018
Thomas JeriOfficerSVP, Commercial32018–2020
University of North Carolina at Chapel Hill Foundation, Inc.TenPercentOwner22018
VOROBYEV MAXIM YURYEVICHTenPercentOwner22018
Wakefield Group III, LLCTenPercentOwner22018
Wakefield Group IV, LLCTenPercentOwner22018
Wildcat Acquisition Holdings (UK) LtdTenPercentOwner22018
Xeraya LT LtdTenPercentOwner22018
Zahir FaresTenPercentOwner22018
AMP&A Management IV, LLCTenPercentOwner22018
A.M. Pappas Life Science Ventures IV LPTenPercentOwner22018
PAPPAS ARTHUR MTenPercentOwner22018
PAPPAS CAPITAL, LLCTenPercentOwner22018
PV IV CEO Fund, L.P.TenPercentOwner22018
1118 LtdTenPercentOwner22018
Katz Richard DOfficerChief Financial Officer32019–2020
Krawchick FlorinaOfficerSVP, Human Resources22019–2020
Horobin JoannaDirector32019–2020
Rielly-Gauvin KatherineDirector32019–2020
ESHELMAN FREDRIC NTenPercentOwner92020
Eshelman Ventures, LLCTenPercentOwner92020
Shah TusharOfficerChief Medical Officer; Chief Medical Oficer22020
Bariahtaris StevenOfficerInterim Chief Financial Ofcr.12020

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2020-01-07Liquidia Technologies IncBiotechnology$22,424,991$22,424,99181
2018-02-20Liquidia Technologies IncBiotechnology$53,312,680$25,500,00071

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationLiquidia Technologies, Inc.NCState business registriesname and state
Business registrationLiquidia Technologies, Inc.NCState business registriesname and state
Business registrationLiquidia Technologies, Inc.NCState business registriesname and state
Business registrationLiquidia Technologies, Inc.NCState business registriesname and state
Business registrationLIQUIDIA TECHNOLOGIES, INC.NCState business registriesname and state
Business registrationLIQUIDIA TECHNOLOGIES, INC.NCState business registriesname and state
Plan sponsorLIQUIDIA TECHNOLOGIES, INC.NCForm 5500 (employee benefit plans)name and state
Federal award recipientLIQUIDIA TECHNOLOGIES, INCNCFederal spending (USAspending)name and state
Form D issuerLiquidia Technologies IncNCForm D private offeringsCIK (EXACT)
Lobbying clientLIQUIDIA TECHNOLOGIES, INC.NCFederal lobbying (LDA)name and state
Paying companyLiquidia Technologies, Inc.NCOpen Payments (drug and device company payments)name and state
Patent assigneeLIQUIDIA TECHNOLOGIES, INC.NCPatents (USPTO)name and state
SEC filerLiquidia Technologies IncSEC filers (EDGAR)CIK (EXACT)
Trademark ownerLiquidia Technologies, Inc.NCTrademarks (USPTO)name and state

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Surgical & Medical Instruments & Apparatus, NC first:

More with this interest.

In other datasets, the same topic (Technology) in NC:

Interests: Surgical & Medical Instruments & Apparatus · Technology